Ultramicrosize Griseofulvin Tablet
Product Images NDC 62135-494

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Ultramicrosize Griseofulvin (NDC 62135-494). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chartwell Rx, Llc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Structural Formula (Ultramicrosize Griseofulvin Tablets Usp 01)

Structural Formula (Ultramicrosize Griseofulvin Tablets Usp 01)
Chemical structure of Griseofulvin showing its molecular formula C17H17ClO6 and molecular weight 352.77. The diagram includes atom groups and bond arrangements characteristic of the compound.*
FDA Label Image

Ndc 62135-494-01ultramicrosizegriseofulvintablets, Usp125 mgrx Only100 Tabletschartwell Rx (Ultramicrosize Griseofulvin Tablets Usp 02)

Ndc 62135-494-01ultramicrosizegriseofulvintablets, Usp125 mgrx Only100 Tabletschartwell Rx (Ultramicrosize Griseofulvin Tablets Usp 02)
Label for Ultramicrosize Griseofulvin Tablets, USP 125 mg by Chartwell RX, LLC. The label indicates the product contains 100 oral tablets and is prescription only. Dosage instructions and storage conditions (20° to 25°C, 68° to 77°F) are noted, along with warnings to keep the medication out of reach of children.*
FDA Label Image

Ndc 62135-494-30ultramicrosizegriseofulvintablets, Usp125 mgrx Only30 Tabletschartwell Rx (Ultramicrosize Griseofulvin Tablets Usp 03)

Ndc 62135-494-30ultramicrosizegriseofulvintablets, Usp125 mgrx Only30 Tabletschartwell Rx (Ultramicrosize Griseofulvin Tablets Usp 03)
Label for Ultramicrosize Griseofulvin Tablets, USP, 125 mg oral tablets, prescription only, containing 30 tablets per package. The label includes manufacturer information for Chartwell Rx, LLC, storage instructions, and a barcode. A note indicates the tablets contain 125 mg of griseofulvin each and the product is made in the USA.*
FDA Label Image

Ndc 62135-495-01ultramicrosizegriseofulvintablets, Usp250 mgrx Only100 Tabletschartwell Rx (Ultramicrosize Griseofulvin Tablets Usp 04)

Ndc 62135-495-01ultramicrosizegriseofulvintablets, Usp250 mgrx Only100 Tabletschartwell Rx (Ultramicrosize Griseofulvin Tablets Usp 04)
Label for Ultramicrosize Griseofulvin Tablets, USP, 250 mg oral tablets by Chartwell RX, LLC. The label indicates the product is Rx only and contains 100 tablets. It includes dosage information, storage instructions, and warnings to keep the medication out of reach of children.*
FDA Label Image

Ndc 62135-495-30ultramicrosizegriseofulvintablets, Usp250 mgrx Only30 Tabletschartwell Rx (Ultramicrosize Griseofulvin Tablets Usp 05)

Ndc 62135-495-30ultramicrosizegriseofulvintablets, Usp250 mgrx Only30 Tabletschartwell Rx (Ultramicrosize Griseofulvin Tablets Usp 05)
Label of Ultramicrosize Griseofulvin Tablets USP, 250 mg strength, oral tablets. The bottle contains 30 tablets and is marked Rx Only. The label includes the Chartwell Rx logo and instructions to see the package insert for dosage. It also features storage information and warnings to keep the medication out of reach of children. Manufactured by Chartwell RX, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.